In order to further implement the "Thirty Opinions of Taizhou Market Supervision and Administration Bureau on Further Optimizing the Business Environment to Develop and Expand Market Entities", continue to stimulate the vitality of pharmaceutical market entities, and help create new glories of the private economy. On April 22, 2022, the service activity of "Entering 100 Cities, Joining Thousands of Enterprises and Hundreds of Enterprises" - Wenling Pharmaceutical Enterprise Symposium was held in Wanbangde China-Africa Science and Technology Park. Ye Xingfu, member of the Party Committee and Deputy Director of Taizhou Market Supervision Bureau and related Head of the department, member of the party committee and deputy director of Wenling Market Supervision Bureau Zhu Keqiang and heads of relevant departments attended the meeting. Representatives of 12 Wenling pharmaceutical companies including Rui Rentang attended the meeting.

Before the meeting, Director Ye and his party visited the product exhibition hall, polymer workshop, sterilization warehouse and fully intelligent three-dimensional warehouse of Wanbangde China-Africa Science and Technology Park, and briefly understood the development orientation and industrial planning of China-Africa Science and Technology Park.

Wanbangde China-Africa Science and Technology Park (medical device industry) started construction in 2019. It is a provincial-level key project in Zhejiang Province. It is the Group's response to the "Belt and Road" development initiative, combining Chinese and South African medical technologies to achieve "interconnection and complementarity" between China and Africa. Circular industrial base. According to the positioning of high automation + informatization and intelligence, the park creates a medical device "complex" integrating R&D, production and sales. The products cover orthopedics, polymers, protective equipment and other medical device fields.

At the symposium, Chen Xingyao, director of the Medical Device Supervision Department of Taizhou Market Supervision Administration, made an in-depth discussion on the policies related to medical devices in the "Thirty Opinions of Taizhou Market Supervision Administration on Further Optimizing the Business Environment to Develop and Expand Market Entities". read. The "Thirty Opinions of Taizhou Market Supervision and Administration Bureau on Further Optimizing the Business Environment to Develop and Expand Market Entities" was released on February 9, 2022. The specific measures include deepening the examination and approval reform of pharmaceutical mechanized production and operation, solving the development problems of the pharmaceutical industry, broadening the Pharmaceutical industry market, strengthening corporate competition compliance guidance, etc. The aim is to further deepen reforms, optimize services, increase speed and efficiency, reduce burdens and reduce costs.

At the meeting, representatives of pharmaceutical companies in Wenling made speeches on business problems and bottlenecks during the epidemic.

After listening carefully to the speeches of the representatives of various enterprises, Director Ye said that the Municipal Bureau will sort out, study and track the questions raised by the representatives as soon as possible, so as to truly solve the blocking points, difficulties and pain points encountered in the operation of pharmaceutical enterprises. At the same time, in order to further optimize the business environment of pharmaceutical companies, the Taizhou Municipal Bureau also issued the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Machinery Industry", which discusses how to speed up and improve efficiency in review and approval, how to improve quality on the implementation platform, and how to In the process of enterprise transformation and development, the file upgrade has been further optimized.